Financial Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences Share by Ken Dropiewski on January 22, 2019 More in Financial: Atrium Therapeutics Reports Second Quarter 2026 Financial Results August 13, 2026 Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results August 13, 2026 Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance August 13, 2026 Share this story Facebook Twitter LinkedIn